We unpack the science behind the ECS and its significance in a range of chronic conditions.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through...
Cannabis Europa panellist and Grow Group's Managing Director, Pierre van Weperen, on the current state of play, and the future of cannabis-based medicine in the UK.
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A...
Dr Alexander Van Heerden: “Doctors Should See Cannabis as a First-Line Treatment Option”
Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer...
